| |
|
|
|
Corbus Pharma  
|
|
7.05 -0.26 (-0.04%) |
06-02 16:00 |
|
Open: |
7.32 |
Pre close: |
7.31 |
Target:
|
8.82 
|
|
High: |
7.34 |
Low: |
6.8801 |
Resistance:
|
7.55
8.66
|
|
Volume: |
1,354,661 |
Market Cap: |
511M |
Support:
|
5.75
4.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.40
|
MACD |
MACD(12,26):
|
0.37 |
|
MA(20): |
7.09  |
Signal(12,26,9): |
0.42 |
|
MA(100): |
5.95 |
Stochastic Oscillator |
%K(14,3):
|
44.53 |
|
MA(250): |
5.72 |
%D(3): |
50.04 |
|
Average Volume(K) |
3-Month: |
105115
|
52-Week |
High:
|
8.66 |
|
10-Days: |
136709 |
Low: |
3.29 |
|
RSI |
RSI(14):
|
52.91 |
Change(%): |
4.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.140 |
Return on Equity (ttm) |
-230.4 |
Shares Out. (M) |
72.49 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-60.4 |
Shares Float (M) |
63.84 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.93 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-6.6 |
% Held by Institutions |
41.18 |
|
Forward EPS |
-1.120 |
Gross Profit (p.s.) |
-0.737 |
Shares Short (K) |
11880 |
|
Book Value (p.s.) |
0.310 |
EBITDA (p.s.) |
-1.098 |
P/E |
-6.18 |
|
Sales Per Share |
0.497 |
Qtrly Earnings Growth |
0.00 |
P/BV |
22.74 |
|
Profit Margin |
-207.87 |
Operating Cash Flow
(M) |
-83.64 |
P/S |
14.19 |
|
Operating Margin |
-223.40 |
Levered Free Cash Flow
(M) |
-63.15 |
P/CF |
-6.11 |
|
|
|
|
|
|
